Business
Why the Aroa Biosurgery (ASX:ARX) share price is lifting today
The Aroa Biosurgery Ltd (ASX: ARX) share price is up 2.6% after the company shared positive news this morning. A new product from the soft-tissue regeneration company has received US Food and Drug Administration (FDA) clearance.
At the time of writing, the Aroa Biosurgery share price is trading at $1.17 after reaching an intraday high of $1.22 this morning.
Let’s look closer at the news of Aroa Biosurgery’s newest FDA cleared product.
Myriad Morcells
The company’s new product, Myriad Morcells, works to “kick start” a wound’s healing, according to Aroa Biosurgery vice president of research and clinical development Dr Barnaby…
-
Noosa News20 hours agoPolice declare emergency zone in Sunshine Coast as person with gun runs through residential streets
-
General22 hours agoVictoria set to have first new national parks in more than a decade
-
Noosa News24 hours agoVictorian farmers welcome spring forecast despite long-term climate concerns
-
General23 hours agoSharp drop in Gouldian finch sightings sparks worry in WA